BioRestorative Therapies, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from BioRestorative Therapies, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 200% in 3 years, but profit fell: $425 less profit per $100 of extra sales. Lower than 93% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 87% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-64.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 77% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$425Sales grew 200% in 3 years, but profit fell: $425 less profit per $100 of extra sales.
Lower than 93% of Healthcare companies in United States.
Asset Productivity Ratio
+200% / -75%In 3 years sales changed by +200% while total assets changed by -75%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
87%Of every $100 the company owns, $87 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 57% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 87% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
BioRestorative Therapies, Inc. made a loss over the last year. BioRestorative Therapies, Inc. owes $0.35 for every $1 it owns. BioRestorative Therapies, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossBioRestorative Therapies, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.68The share price is 0.68 times BioRestorative Therapies, Inc.'s book value per share, lower than 86% of Healthcare companies in United States.
Market cap
$2 MThe total market value of all of BioRestorative Therapies, Inc.'s shares at today's price (share price × number of shares), smaller than 98% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$3 MWhat BioRestorative Therapies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
$2.19Net worth divided by the number of shares. The share price of $1.50 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-241.1%BioRestorative Therapies, Inc. lost 241.1% of its shareholders' money over the last year, lower than 87% of Healthcare companies in United States.
Owes vs Owns
0.35×BioRestorative Therapies, Inc. owes $0.35 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.
Dividend yield
NoneBioRestorative Therapies, Inc. does not currently pay a dividend.
Revenue growth
-10%Revenue fell 10% in the year to Dec 2025, and grew 44% a year on average over 3 years.
Profit growth
LossBioRestorative Therapies, Inc. made a loss in each of the last two years.
Profit margin
-3959.4%BioRestorative Therapies, Inc. lost $3959 for every $100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For BioRestorative Therapies, Inc.: $2 M ÷ $3 M (31 Mar 2026) = 0.7.
What is BioRestorative Therapies, Inc.'s return on equity?
BioRestorative Therapies, Inc. lost 241.1% of its shareholders' money over the last year, lower than 87% of Healthcare companies in United States.
How much does BioRestorative Therapies, Inc. owe compared with what it owns?
BioRestorative Therapies, Inc. owes $0.35 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.
Does BioRestorative Therapies, Inc. pay a dividend?
No. BioRestorative Therapies, Inc. does not currently pay a dividend.
Is BioRestorative Therapies, Inc.'s revenue growing?
Revenue fell 10% in the year to Dec 2025, and grew 44% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.